Gilde Healthcare has invested in Tandarts Today

Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.

Tandarts Today, founded in 2015, offers all disciplines of regular dentistry, including special treatments such as implantology, orthodontics, periodontology and aesthetic treatments. Furthermore, through its own dental laboratories, it develops hockey bits, custom-made prostheses, bridges and other dental work pieces.

Gilde Healthcare is a specialized European healthcare investor managing over US$1.5 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies, with a focus on the Benelux and DACH regions. The private equity fund targets healthcare, suppliers of medical products and service providers in the healthcare market.

Oaklins’ team in the Netherlands acted as the exclusive financial advisor to the seller in this transaction.

Usługi

Doradztwo transakcyjne przy sprzedaży firm

Strony

“I am delighted to welcome Gilde Healthcare as a shareholder in Tandarts Today. Their experience in buy-and-build strategies combined with their healthcare angle and focus makes Gilde Healthcare the perfect partner to realize Tandarts Today’s growth objectives. Oaklins played a fundamental role in identifying Gilde Healthcare as a buyer and realizing the transaction in a dedicated and professional manner.”

Ruben Hoefnagels

Founder and CEO, Tandarts Today

Porozmawiaj z zespołem obsługi transakcji

Adse de Kock

Partner

Amsterdam, Holandia
Oaklins Netherlands

Wyświetl profil Skontaktuj się

Sander van 't Spijker

Wicedyrektor

Amsterdam, Holandia
Oaklins Netherlands

Wyświetl profil Skontaktuj się

Powiązane transakcje

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

Opieka zdrowotna

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Więcej informacji

Armira has signed an agreement to acquire a majority stake in Viabus

Private Equity | Dobra konsumpcyjne i handel detaliczny

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Więcej informacji

Triscan has joined APA and Riverarch to accelerate growth in the European aftermarket

Private Equity | Motoryzacja

Triscan has joined APA and Riverarch to accelerate growth in the European aftermarket

Triscan AS, a leading provider of OE-quality automotive spare parts for the professional aftermarket in Europe, has been acquired by APA Industries, LLC, a portfolio company of Riverarch Equity Partners.

Więcej informacji